Novel de novo SHANK3 mutation in autistic patients
Julie Gauthier(Centre Hospitalier Universitaire Sainte-Justine), Guy A. Rouleau(Montreal Neurological Institute and Hospital), Amélie Piton(Centre National de la Recherche Scientifique), Laurent Mottron(Centres Intégré Universitaires de Santé et de Services Sociaux), Patrick Cossette(Centre Hospitalier de l’Université de Montréal), Claude Marineau(Centre Hospitalier de l’Université de Montréal), Pierre Drapeau(Université de Montréal), Ridha Joober(McGill University), Dan Spiegelman(Montreal Neurological Institute and Hospital), Ronald G. Lafrenière(Xenon Pharmaceuticals (Canada)), Fadi F. Hamdan(Centre Hospitalier Universitaire Sainte-Justine), Line Lapointe(Hôpital Notre-Dame), Sandra B. Laurent(McGill University Health Centre), Judith St‐Onge(Seattle Children's Hospital), Éric Fombonne(Oregon Health & Science University)
American Journal of Medical Genetics Part B Neuropsychiatric Genetics
July 9, 2008
Cited by 324
Related Papers
Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci
|Neuron|2015|1.5k
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis
|Nature Genetics|2008|1.5k
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
|Nature Genetics|2012|752